Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A: In Phase 3 clinical trials, participants lost an average of approximately 7.9% to 8.7% of their total body weight over 36 to 40 weeks
10.1016/j.bbr.2008.12.016 120 Pinto PayaresD
No fillers or additives
doi: 10.1093/cercor/bht118 82
& Battistel, E
Modulation of enzymes involved in NAD + consumption and synthesis In addition to NAD + precursor-based strategies, halting of processes linked to NAD + consumption or biosynthesis represents a complementary and therapeutically appealing approach to alter or restore NAD + homeostasis in context-specific applications
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
